07:30
creatine
Rhonda Patrick argues that creatine's cognitive benefits are real but conditional: unlike the muscle-building effects (easily measured in a 12-week study), brain benefits only show up under conditions of "brain stress" — sleep deprivation, psychological/emotional stress, aging, or neurodegenerative disease — and require doses well above the standard 5 grams because muscle tissue preferentially consumes creatine before it reaches the brain in adequate amounts.
Physical-performance effects of creatine are easy to prove objectively in a short (12-week) study; cognitive effects are much harder to demonstrate and measure.
Creatine does cross the blood-brain barrier (established), but at doses up to ~5g/day the muscles consume most of it first, especially in people who train.
Dosing under-powers many existing cognition studies: a study run at 5g/day that finds no effect risks a false-negative conclusion about creatine and the brain.
Creatine's cognitive benefit is framed as working 'in the background of stress' — analogous to muscle needing to be mechanically stressed (exercise) for creatine to build strength.
'Stress' for brain purposes includes sleep deprivation, psychological/emotional stress, exam-type stress, aging, and neurodegenerative disease — any state that compromises or taxes brain function.
The brain uses about 20% of total caloric intake despite weighing under 2% of body weight, which is offered as the rationale for why extra creatine (faster energy recycling) would help most when brain energy demand is elevated.
Cognition studies on creatine typically test processing speed and memory using standard test batteries.
Older adults appear to benefit from supplemental creatine, framed as aging itself being a form of brain stress.
A pilot study (researchers described as relatively unknown/junior) gave Alzheimer's patients 20g/day of creatine with an apparent placebo control and found improved cognitive function; the same patients also gained strength and lean body mass when combined with exercise.
Peter Attia frames prevention — intervening 10-20 years before onset in people most susceptible to a metabolic path toward dementia — as the most important and hardest-to-study question, distinguishing inflammatory, lipid/vascular, and metabolic paths to Alzheimer's disease.
Rhonda Patrick states there is 'really no downside' to 10 grams/day and predicts 10g will replace 5g as the new baseline recommended dose.
Patrick's personal protocol: 5g doses (to avoid GI issues from a single large dose), mixed into water or tea, taken mostly before noon; she raises her dose to 15-20g/day under added stress (e.g., after jet lag/sleep deprivation from a trip to China).
Patrick reports a subjective effect: she avoids afternoon sleepiness when taking more than 5g, but flags this could be placebo and says that wouldn't matter since the effect is working for her either way.
The described dosing confound (muscle uptake competing with brain uptake at 5g) offers a mechanistic explanation for why the cognitive-creatine literature looks mixed or unconvincing to date — it reframes 'creatine doesn't help cognition' findings as possibly 'creatine was underdosed for the brain.'
The 'stress-gating' model reframes creatine as a conditional, not universal, cognitive enhancer: benefits are proposed to appear specifically when brain energy demand is already elevated (aging, sleep loss, disease), rather than as a general-population nootropic.
The Alzheimer's prevention argument ties a hypothesized 'metabolic subtype' of Alzheimer's disease to a rationale for creatine as an ATP-substrate intervention started years to decades before disease onset in susceptible individuals — a prevention hypothesis rather than a proven treatment.
Patrick's real-world heuristic (10g baseline, split into 5g doses, timed before noon, escalated to 15-20g under acute stress like travel) is presented as running ahead of formal dosing guidelines, based on personal practice rather than trial data.
«It it is. However, the muscles are greedy as hell.»
— 00:46
«With the brain, it works in the background of stress.»
— 01:45
«anybody listening, if you're not under stress, I'd like to hear from you. I want to know what you're doing.»
— 02:27
«20% of our total caloric intake goes to an organ that weighs less than 2% of your body weight. It is the most insane statistic of the human body.»
— 02:48
«and they were given 20 grams of creatine and it improved cognitive function in these in these patients with Alzheimer's disease»
— 04:17
«I think that creatine for the brain is the most interesting aspect of this area of research right now»
— 05:44
«there's really no downside to doing 10 grams a day.»
— 05:56
Reception
Predominantly positive reception with engaged testimonials of health benefits, humorous engagement, and isolated skepticism that garners minimal agreement.
The segment presents creatine's cognitive benefit as plausible and mechanistically reasoned (dose, brain-stress gating, ATP/energy demand) but resting on thin, early-stage evidence — a small, non-well-known pilot study in Alzheimer's patients, general aging-cohort observations, and personal n=1 anecdotes — with the 'no downside to 10 grams' claim offered as the speakers' working rationale rather than a settled finding.
07:30